Loading…
2 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 14,168 | 14,530 | 15,491 | 23,792 | 17,688 | 17,821 | 18,842 |
| EBITDA | 2,166 | 1,775 | 1,433 | 5,601 | 252 | 286 | 1,103 |
| Net profit | 184 | -389 | -299 | 3,842 | -438 | -476 | -2 |
| Total assets | 18,693 | 19,334 | 19,323 | 19,622 | 16,838 | 15,754 | 16,499 |
| n (companies reporting) | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
GEL, thousands
| Company | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Clinic-LJ | 10,586 | 10,643 | 9,229 | 11,372 | 11,671 | 13,521 | 15,596 |
| LJ Da Ko - Tuberkulozis… | 3,582 | 3,887 | 6,262 | 12,420 | 6,017 | 4,300 | 3,246 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.